[Effect of clarithromycin in extending the life expectancy of patients with non-small-cell lung cancer].
Ieshiro
R
R
Goto
G
G
Ota
T
T
Yuasa
K
K
Iguchi
M
M
Okamura
J
J
D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000628:therapy*; D017291:Clarithromycin / Q000494:pharmacology / Q000627:therapeutic use*; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D066298:In Vitro Techniques; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects; D008175:Lung Neoplasms / Q000401:mortality / Q000628:therapy*; D008297:Male; D015996:Survival Rate
D000900:Anti-Bacterial Agents; D007155:Immunologic Factors; D004917:Erythromycin; D017291:Clarithromycin